Extended evaluation of recombinant human activated protein C united states trial (ENHANCE US) – a singlearm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis - Bernard, GR; Margolis, BD; Shanies, HM (Chest, 2004)
et al.